<DOC>
	<DOCNO>NCT01657825</DOCNO>
	<brief_summary>The purpose study assess effect multiple dose isavuconazole pharmacokinetics ( PK ) warfarin single dose administration .</brief_summary>
	<brief_title>Drug Interaction Study Isavuconazole Warfarin Healthy Male Subjects</brief_title>
	<detailed_description>Subjects receive single dose warfarin Day 1 follow 15 day wash-out period ( time warfarin dose isavuconazole dosing ) . On Days 16 17 , isavuconazole dose three time daily ( TID ) . TID dose administer 8 hour apart . On Days 18 28 , isavuconazole administer daily ( QD ) . All subject administer single dose warfarin Day 20 . A follow visit occur approximately 7 day last dose isavuconazole . Blood sample pharmacokinetics collect throughout study .</detailed_description>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Subjects must BMI 18 32 kg/m2 body weight least 45 kg Subjects must normal laboratory value especially ALT , AST , protein C S , prothrombin time The subject history unexplained syncope , cardiac arrest , unexplained cardiac arrhythmia torsade de pointes , structural heart disease , family history Long QT syndrome ( suggest sudden death close relative young age due possible probable cardiac cause ) The subject positive result hepatitis C antibodies hepatitis B surface antigen Screening know positive human immunodeficiency virus ( HIV ) The subject know suspect allergy component trial product azole class compound , history multiple and/or severe allergy drug food ( judge investigator ) , history severe anaphylactic reaction The subject smoker ( use tobacco nicotine containing product ) within 6 month prior Screening The subject treatment prescription drug complementary alternative medicine within 14 day prior Day 1 , overthecounter medication within 1 week prior Day 1 The subject receive experimental agent within 30 day 5 halflives , whichever long prior Day 1 The subject recent history ( within last 2 year ) drug alcohol abuse , define investigator , positive drug and/or alcohol screen</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>isavuconazole</keyword>
	<keyword>warfarin</keyword>
	<keyword>Healthy Volunteers</keyword>
	<keyword>BAL8557</keyword>
	<keyword>Coumadin</keyword>
</DOC>